REVIEW: Aortic Atheromas: Current Concepts and Controversies-A Review of the Literature (original) (raw)

Abstract

The frequent use of transesophageal echocardiogram (TEE) has led to the increased recognition of aortic atheromas. Retrospective and prospective follow-up studies have reported an association between aortic atheromas and stroke in the high-risk patient population, with complex plaques being more likely to embolize than simple plaques. However, TEE-based studies in the low-risk cohorts have failed to show a similar association. There is growing body of evidence suggesting that aortic atheroma is a marker of generalized atherosclerosis. Although magnetic resonance (MR) imaging and computed tomography (CT) scan are emerging as a powerful noninvasive tool for characterization of aortic atheromas, TEE is the imaging modality of choice. Currently, treatment of aortic atheromas is not well defined, and mixed outcomes have been reported for anticoagulation therapy with warfarin. Statins appear promising based on their plaque stabilization properties. However, there are no randomized control trials to establish the role of both anticoagulation and statins in patients with aortic atheromas, and are warranted in the future. (ECHOCARDIOGRAPHY, Volume 25, February 2008) aortic atheroma, mobile components, stroke, thoracic aorta, transesophageal echocardiogram, vascular imaging Stroke is the third leading cause of death in United States, with approximately 40% of them being cryptogenic in etiology. 1 Since the introduction of transesophageal echocardiogram (TEE), aortic atheromatous plaque, also referred to as aortic atheroma, has been suspected to be a hidden source of embolic stroke. It is unclear whether aortic atheroma is a risk factor for stroke, or a risk marker for generalized atherosclerosis, or an innocent bystander. 2 Due to this uncertainty, clinicians face a dilemma in treating patients with aortic atheromas. This review discusses the classification of aortic theromatous plaques, their epidemiology, and the clinical trials that have studied their embolic risk. It also details current diagnostic imaging tools and treatment options.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (91)

  1. Thom T, Haase N, Rosamond W, et al: Heart dis- ease and stroke statistics-2006 update: A report from 204 ECHOCARDIOGRAPHY: A Jrnl. of CV Ultrasound & Allied Tech. Vol. 25, No. 2, 2008
  2. EPIDEMIOLOGY, CLINICAL SIGNIFICANCE, AND MANAGEMENT OF AORTIC ATHEROMAS the American Heart Association Statistics Commit- tee and Stroke Statistics Subcommittee. Circulation 2006;113:e85-e151.
  3. Adams HP, Jr: Cardiac disease and stroke: will history repeat itself? Mayo Clin Proc 2006;81:597-601.
  4. Amarenco P, Duyckaerts C, Tzourio C, et al: The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992;326:221-225.
  5. Hausmann D, Gulba D, Bargheer K, et al: Success- ful thrombolysis of an aortic-arch thrombus in a patient after mesenteric embolism. N Engl J Med 1992;327:500-501.
  6. Freedberg RS, Tunick PA, Culliford AT, et al: Dis- appearance of a large intraaortic mass in a pa- tient with prior systemic embolization. Am Heart J 1993;125:1445-1447.
  7. Bansal RC, Pauls GL, Shankel SW: Blue digit syn- drome: transesophageal echocardiographic identifica- tion of thoracic aortic plaque-related thrombi and suc- cessful outcome with warfarin. J Am Soc Echocardiogr 1993;6:319-323.
  8. Montgomery DH, Ververis JJ, McGorisk G, et al: Nat- ural history of severe atheromatous disease of the thoracic aorta: a transesophageal echocardiographic study. J Am Coll Cardiol 1996;27:95-101.
  9. Amarenco P, Cohen A, Tzourio C, et al: Atheroscle- rotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994;331:1474-1479.
  10. Meissner I, Khandheria BK, Sheps SG, et al: Atherosclerosis of the aorta: Risk factor, risk marker, or innocent bystander? A prospective population- based transesophageal echocardiography study. J Am Coll Cardiol 2004;44:1018-1024.
  11. Sheikhzadeh A, Ehlermann P, Mirau W: Atheromato- sis of the aortic arch: stable and unstable plaques. Eur Heart J 2001;22:1361-1362.
  12. Agmon Y, Khandheria BK, Meissner I, et al: Relation of coronary artery disease and cerebrovascular disease with atherosclerosis of the thoracic aorta in the gen- eral population. Am J Cardiol 2002;89:262-267.
  13. Demopoulos LA, Tunick PA, Bernstein NE, et al: Pro- truding atheromas of the aortic arch in symptomatic patients with carotid artery disease. Am Heart J 1995;129:40-44.
  14. Fazio GP, Redberg RF, Winslow T, et al: Transeso- phageal echocardiographically detected atheroscle- rotic aortic plaque is a marker for coronary artery dis- ease. J Am Coll Cardiol 1993;21:144-150.
  15. Heiskell CA, Conn J, Jr: Aortoarterial emboli. Am J Surg 1976;132:4-7.
  16. Gore I, Collins DP: Spontaneous atheromatous em- bolization. Review of the literature and a report of 16 additional cases. Am J Clin Pathol 1960;33:416-426.
  17. Tunick PA, Kronzon I: Protruding atherosclerotic plaque in the aortic arch of patients with systemic embolization: a new finding seen by transesophageal echocardiography. Am Heart J 1990;120:658-660.
  18. Karalis DG, Chandrasekaran K, Victor MF, et al: Recognition and embolic potential of intraaortic atherosclerotic debris. J Am Coll Cardiol 1991;17:73- 78.
  19. Nihoyannopoulos P, Joshi J, Athanasopoulos G, et al: Detection of atherosclerotic lesions in the aorta by transesophageal echocardiography. Am J Cardiol 1993;71:1208-1212.
  20. Mitusch R, Stierle U, Tepe C, et al: Systemic em- bolism in aortic arch atheromatosis. Eur Heart J 1994;15:1373-1380.
  21. Tunick PA, Perez JL, Kronzon I: Protruding athero- mas in the thoracic aorta and systemic embolization. Ann Intern Med 1991;115:423-427.
  22. Di Tullio MR, Sacco RL, Gersony D, et al: Aor- tic atheromas and acute ischemic stroke: A trans- esophageal echocardiographic study in an ethnically mixed population. Neurology 1996;46:1560-1566.
  23. Stone DA, Hawke MW, LaMonte M, et al: Ulcer- ated atherosclerotic plaques in the thoracic aorta are associated with cryptogenic stroke: a multiplane transesophageal echocardiographic study. Am Heart J 1995;130:105-108.
  24. Di Tullio MR, Sacco RL, Savoia MT, et al: Aor- tic atheroma morphology and the risk of ischemic stroke in a multiethnic population. Am Heart J 2000;139:329-336.
  25. Khatibzadeh M, Mitusch R, Stierle U, et al: Aortic atherosclerotic plaques as a source of systemic em- bolism. J Am Coll Cardiol 1996;27:664-669.
  26. Tunick PA, Rosenzweig BP, Katz ES, et al: High risk for vascular events in patients with protruding aor- tic atheromas: a prospective study. J Am Coll Cardiol 1994;23:1085-1090.
  27. The French Study of Aortic Plaques in Stroke Group: Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 1996;334:1216-1221.
  28. Mitusch R, Doherty C, Wucherpfennig H, et al: Vas- cular events during follow-up in patients with aortic arch atherosclerosis. Stroke 1997;28:36-39.
  29. The Stroke Prevention in Atrial Fibrillation In- vestigators Committee on Echocardiography: Trans- esophageal echocardiographic correlates of throm- boembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998;128:639-647.
  30. Fujimoto S, Yasaka M, Otsubo R, et al: Aortic arch atherosclerotic lesions and the recurrence of ischemic stroke. Stroke 2004;35:1426-1429.
  31. Cohen A, Tzourio C, Bertrand B, et al: Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke. Circulation 1997;96:3838-3841.
  32. Petty GW, Khandheria BK, Meissner I, et al: Population-based study of the relationship between atherosclerotic aortic debris and cerebrovascular is- chemic events. Mayo Clin Proc 2006;81:609-614.
  33. Meissner I, Whisnant JP, Khandheria BK, et al: Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ul- trasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc 1999;74:862-869.
  34. Tunick PA, Kronzon I: Atherosclerosis of the aorta: a risk factor, risk marker, or an innocent bystander? J Am Coll Cardiol 2005;45:1907; author reply 1907.
  35. Reynolds HR, Tunick PA, Kort S, et al: Abdominal aor- tic aneurysms and thoracic aortic atheromas. J Am Soc Echocardiogr 2001;14:1127-1131.
  36. Weisenberg D, Sahar Y, Sahar G, et al: Atheroscle- rosis of the aorta is common in patients with severe aortic stenosis: an intraoperative transesophageal echocardiographic study. J Thorac Cardiovasc Surg 2005;130:29-32.
  37. Adler Y, Vaturi M, Wiser I, et al: Nonobstructive aortic valve calcium as a window to atherosclerosis of the aorta. Am J Cardiol 2000;86:68-71.
  38. Nam HS, Han SW, Lee JY, et al: Association of aortic plaque with intracranial atherosclerosis in patients with stroke. Neurology 2006;67:1184-1188.
  39. Adler Y, Vaturi M, Fink N, et al: Association between mitral annulus calcification and aortic atheroma: a prospective transesophageal echocardiographic study. Atherosclerosis 2000;152:451-456.
  40. Tribouilloy C, Shen WF, Peltier M, et al: Noninva- sive prediction of coronary artery disease by trans- esophageal echocardiographic detection of thoracic aortic plaque in valvular heart disease. Am J Cardiol 1994;74:258-260.
  41. Davila-Roman VG, Barzilai B, Wareing TH, et al: In- traoperative ultrasonographic evaluation of the as- cending aorta in 100 consecutive patients undergoing cardiac surgery. Circulation 1991;84:III47-53.
  42. Keeley EC, Grines CL: Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. J Am Coll Cardiol 1998;32:1861-1865.
  43. Davila-Roman VG, Murphy SF, Nickerson NJ, et al: Atherosclerosis of the ascending aorta is an indepen- dent predictor of long-term neurologic events and mor- tality. J Am Coll Cardiol 1999;33:1308-1316.
  44. Van Der Linden J, Hadjinikolaou L, Bergman P, et al: Postoperative stroke in cardiac surgery is related to the location and extent of atherosclerotic disease in the ascending aorta. J Am Coll Cardiol 2001;38:131- 135.
  45. Feder W, Auerbach R: "Purple toes": an uncommon se- quela of oral coumarin drug therapy. Ann Intern Med 1961;55:911-917.
  46. Hyman BT, Landas SK, Ashman RF, et al: Warfarin-related purple toes syndrome and choles- terol microembolization. Am J Med 1987;82:1233- 1237.
  47. Ben-Chitrit S, Korzets Z, Hershkovitz R, et al: Choles- terol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasmino- gen activator. Nephrol Dial Transplant 1994;9:428- 430.
  48. Bucher A, Roald B: Cholesterol embolization after in- travenous streptokinase therapy in acute myocardial infarction. Tidsskr Nor Laegeforen 1993;113:1844- 1845.
  49. Liew YP, Bartholomew JR: Atheromatous emboliza- tion. Vasc Med 2005;10:309-326.
  50. Katz ES, Konecky N, Tunick PA, et al: Visualiza- tion and identification of the left common carotid and left subclavian arteries: a transesophageal echocardio- graphic approach. J Am Soc Echocardiogr 1996;9:58- 61.
  51. Weinberger J, Azhar S, Danisi F, et al: A new non- invasive technique for imaging atherosclerotic plaque in the aortic arch of stroke patients by transcutaneous real-time B-mode ultrasonography: an initial report. Stroke 1998;29:673-676.
  52. Khoury Z, Rinat C, Benhorin J, et al: Quantifi- cation of atherosclerotic burden in the descend- ing aorta by transesophageal echocardiography: inter-and intraobserver variability. Echocardiogra- phy 1998;15:59-66.
  53. Zaidat OO, Suarez JI, Hedrick D, et al: Reproducibil- ity of transesophageal echocardiography in evaluating aortic atheroma in stroke patients. Echocardiography 2005;22:326-330.
  54. Tunick PA, Krinsky GA, Lee VS, et al: Diagnostic imaging of thoracic aortic atherosclerosis. AJR Am J Roentgenol 2000;174:1119-1125.
  55. Krinsky GA, Freedberg R, Lee VS, et al: In- nominate artery atheroma: a lesion seen with gadolinium-enhanced MR angiography and often missed by transesophageal echocardiography. Clin Imaging 2001;25:251-257.
  56. Min JK, Spencer KT, Furlong KT, et al: Clini- cal features of complications from transesophageal echocardiography: a single-center case series of 10,000 consecutive examinations. J Am Soc Echocardiogr 2005;18:925-929.
  57. Barzilai B, Marshall WG, Jr., Saffitz JE, et al: Avoidance of embolic complications by ultrasonic characterization of the ascending aorta. Circulation 1989;80:I275-279.
  58. Davila-Roman VG, Phillips KJ, Daily BB, et al: In- traoperative transesophageal echocardiography and epiaortic ultrasound for assessment of atherosclerosis of the thoracic aorta. J Am Coll Cardiol 1996;28:942- 947.
  59. Krinsky GA: Diagnostic imaging of aortic atheroscle- rosis and its complications. Neuroimaging Clin N Am 2002;12:437-443.
  60. Fayad ZA, Nahar T, Fallon JT, et al: In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation 2000;101:2503-2509.
  61. Kramer CM, Cerilli LA, Hagspiel K, et al: Mag- netic resonance imaging identifies the fibrous cap in atherosclerotic abdominal aortic aneurysm. Circula- tion 2004;109:1016-1021.
  62. Corti R, Fuster V, Fayad ZA, et al: Lipid lowering by simvastatin induces regression of human atheroscle- rotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 2002;106:2884-2887.
  63. Lima JA, Desai MY, Steen H, et al: Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation 2004;110:2336-2341.
  64. Helft G, Worthley SG, Fuster V, et al: Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imaging. Cir- culation 2002;105:993-998.
  65. Tenenbaum A, Garniek A, Shemesh J, et al: Dual- helical CT for detecting aortic atheromas as a source of stroke: comparison with transesophageal echocar- diography. Radiology 1998;208:153-158.
  66. Ross R: Atherosclerosis is an inflammatory disease. Am Heart J 1999;138:S419-S420.
  67. Davies MJ: Stability and instability: two faces of coro- nary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 1996;94:2013-2020.
  68. Rudd JH, Warburton EA, Fryer TD, et al: Imag- ing atherosclerotic plaque inflammation with [18F]- fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708-2711.
  69. Tawakol A, Migrino RQ, Bashian GG, et al: In vivo 18F-fluorodeoxyglucose positron emission tomog- raphy imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006;48:1818-1824.
  70. Zhang Z, Machac J, Helft G, et al: Non-invasive imag- ing of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological corre- lation. BMC Nucl Med 2006;6:3.
  71. Tahara N, Kai H, Ishibashi M, et al: Simvas- tatin attenuates plaque inflammation: evaluation by EPIDEMIOLOGY, CLINICAL SIGNIFICANCE, AND MANAGEMENT OF AORTIC ATHEROMAS fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006;48:1825-1831.
  72. O'Driscoll G, Green D, Taylor RR: Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997;95:1126-1131.
  73. Laufs U, La Fata V, Plutzky J, et al: Upregulation of endothelial nitric oxide synthase by HMG CoA reduc- tase inhibitors. Circulation 1998;97:1129-1135.
  74. Endres M, Laufs U: Effects of statins on endothelium and signaling mechanisms. Stroke 2004;35:2708- 2711.
  75. Aviram M, Dankner G, Cogan U, et al: Lovastatin in- hibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies. Metabolism 1992;41:229-235.
  76. Kimura M, Kurose I, Russell J, et al: Effects of flu- vastatin on leukocyte-endothelial cell adhesion in hy- percholesterolemic rats. Arterioscler Thromb Vasc Biol 1997;17:1521-1526.
  77. Negre-Aminou P, van Vliet AK, van Erck M, et al: Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; com- parison with other human cell types. Biochim Biophys Acta 1997;1345:259-268.
  78. Notarbartolo A, Davi G, Averna M, et al: Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. Arte- rioscler Thromb Vasc Biol 1995;15:247-251.
  79. Le Quan Sang KH, Levenson J, Megnien JL, et al: Platelet cytosolic Ca2+ and membrane dynamics in patients with primary hypercholesterolemia. Ef- fects of pravastatin. Arterioscler Thromb Vasc Biol 1995;15:759-764.
  80. Rauch U, Osende JI, Chesebro JH, et al: Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. Atherosclerosis 2000;153:181-189.
  81. Dangas G, Smith DA, Unger AH, et al: Pravastatin: an antithrombotic effect independent of the cholesterol- lowering effect. Thromb Haemost 2000;83:688-692.
  82. Tunick PA, Nayar AC, Goodkin GM, et al: Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol 2002;90:1320-1325.
  83. Corti R, Fuster V, Fayad ZA, et al: Effects of ag- gressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high- resolution magnetic resonance imaging. J Am Coll Cardiol 2005;46:106-112.
  84. Yonemura A, Momiyama Y, Fayad ZA, et al: Ef- fect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninva- sive magnetic resonance imaging. J Am Coll Cardiol 2005;45:733-742.
  85. Ferrari E, Vidal R, Chevallier T, et al: Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardiol 1999;33:1317-1322.
  86. Dressler FA, Craig WR, Castello R, et al: Mobile aortic atheroma and systemic emboli: efficacy of anticoagula- tion and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol 1998;31:134-138.
  87. Blackshear JL, Zabalgoitia M, Pennock G, et al: War- farin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. SPAF TEE In- vestigators. Stroke Prevention and Atrial Fibrilla- tion. Transesophageal echocardiography. Am J Car- diol 1999;83:453-455, A459.
  88. Choukroun EM, Labrousse LM, Madonna FP, et al: Mobile thrombus of the thoracic aorta: diagnosis and treatment in 9 cases. Ann Vasc Surg 2002;16:714-722.
  89. Bergman P, Van Der Linden J: Atherosclerosis of the ascending aorta as a major determinant of the out- come of cardiac surgery. Nat Clin Pract Cardiovasc Med 2005;2:246-251; quiz 269.
  90. Djaiani GN: Aortic arch atheroma: stroke reduction in cardiac surgical patients. Semin Cardiothorac Vasc Anesth 2006;10:143-157.
  91. Kronzon I, Tunick PA: Aortic atherosclerotic disease and stroke. Circulation 2006;114:63-75.